Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 |
| Sales and marketing | 4.0 | 1.2 | 0.6 |
| Research and development | 46.6 | 27.6 | 28.1 |
| General and administrative | 46.4 | 8.0 | 7.9 |
| EBIT | -96.9 | -36.7 | -36.6 |
| Pre-tax income | -95.0 | -36.6 | -35.8 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% |
| Net income | -95.0 | -36.6 | -35.8 |
| |
| Diluted EPS | ($1.19) | ($6.84) | ($6.95) |
| Shares outstanding (diluted) | 79.6 | 5.4 | 5.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|